Sartorius AG
XETRA:SRT

Watchlist Manager
Sartorius AG Logo
Sartorius AG
XETRA:SRT
Watchlist
Price: 175.8 EUR 4.64% Market Closed
Market Cap: 12.1B EUR
Have any thoughts about
Sartorius AG?
Write Note

Intrinsic Value

The intrinsic value of one SRT stock under the Base Case scenario is 188.65 EUR. Compared to the current market price of 175.8 EUR, Sartorius AG is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SRT Intrinsic Value
188.65 EUR
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Sartorius AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SRT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SRT?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Sartorius AG

Provide an overview of the primary business activities
of Sartorius AG.

What unique competitive advantages
does Sartorius AG hold over its rivals?

What risks and challenges
does Sartorius AG face in the near future?

Has there been any significant insider trading activity
in Sartorius AG recently?

Summarize the latest earnings call
of Sartorius AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sartorius AG.

Provide P/S
for Sartorius AG.

Provide P/E
for Sartorius AG.

Provide P/OCF
for Sartorius AG.

Provide P/FCFE
for Sartorius AG.

Provide P/B
for Sartorius AG.

Provide EV/S
for Sartorius AG.

Provide EV/GP
for Sartorius AG.

Provide EV/EBITDA
for Sartorius AG.

Provide EV/EBIT
for Sartorius AG.

Provide EV/OCF
for Sartorius AG.

Provide EV/FCFF
for Sartorius AG.

Provide EV/IC
for Sartorius AG.

Show me price targets
for Sartorius AG made by professional analysts.

What are the Revenue projections
for Sartorius AG?

How accurate were the past Revenue estimates
for Sartorius AG?

What are the Net Income projections
for Sartorius AG?

How accurate were the past Net Income estimates
for Sartorius AG?

What are the EPS projections
for Sartorius AG?

How accurate were the past EPS estimates
for Sartorius AG?

What are the EBIT projections
for Sartorius AG?

How accurate were the past EBIT estimates
for Sartorius AG?

Compare the revenue forecasts
for Sartorius AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sartorius AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sartorius AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sartorius AG compared to its peers.

Compare the P/E ratios
of Sartorius AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Sartorius AG with its peers.

Analyze the financial leverage
of Sartorius AG compared to its main competitors.

Show all profitability ratios
for Sartorius AG.

Provide ROE
for Sartorius AG.

Provide ROA
for Sartorius AG.

Provide ROIC
for Sartorius AG.

Provide ROCE
for Sartorius AG.

Provide Gross Margin
for Sartorius AG.

Provide Operating Margin
for Sartorius AG.

Provide Net Margin
for Sartorius AG.

Provide FCF Margin
for Sartorius AG.

Show all solvency ratios
for Sartorius AG.

Provide D/E Ratio
for Sartorius AG.

Provide D/A Ratio
for Sartorius AG.

Provide Interest Coverage Ratio
for Sartorius AG.

Provide Altman Z-Score Ratio
for Sartorius AG.

Provide Quick Ratio
for Sartorius AG.

Provide Current Ratio
for Sartorius AG.

Provide Cash Ratio
for Sartorius AG.

What is the historical Revenue growth
over the last 5 years for Sartorius AG?

What is the historical Net Income growth
over the last 5 years for Sartorius AG?

What is the current Free Cash Flow
of Sartorius AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sartorius AG.

Business Breakdown

Sartorius AG is a globally recognized leader in the biopharmaceutical and laboratory equipment sectors, dedicated to enhancing the efficiency of research and production processes. Founded in 1870 and headquartered in Göttingen, Germany, this innovative company provides a comprehensive range of products and services that support the life sciences industry—from advanced laboratory instruments to high-quality access materials for biopharmaceutical manufacturing. As the demand for biotechnological solutions continues to rise, particularly in response to global health challenges, Sartorius stands out by offering critical tools and technologies, positioning itself at the forefront of a thriving ma...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sartorius AG

Current Assets 2B
Cash & Short-Term Investments 611m
Receivables 393m
Other Current Assets 965.1m
Non-Current Assets 7.8B
Long-Term Investments 103.3m
PP&E 2.2B
Intangibles 5.4B
Other Non-Current Assets 85.9m
Current Liabilities 977m
Accounts Payable 226.3m
Accrued Liabilities 125.1m
Other Current Liabilities 625.6m
Non-Current Liabilities 6.1B
Long-Term Debt 4.4B
Other Non-Current Liabilities 1.7B
Efficiency

Earnings Waterfall
Sartorius AG

Revenue
3.3B EUR
Cost of Revenue
-1.9B EUR
Gross Profit
1.5B EUR
Operating Expenses
-1B EUR
Operating Income
416.7m EUR
Other Expenses
-333.5m EUR
Net Income
83.2m EUR

Free Cash Flow Analysis
Sartorius AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the first quarter of 2024, the company saw a mixed performance. Order intake grew by almost 10%, driven mainly by the Americas, while sales revenue decreased by 7.5% compared to the strong numbers seen in the previous year. China showed the weakest performance in both order intake and sales. Profitability remained robust with an EBITDA margin of 28.6%. The company maintains its full-year guidance, projecting mid- to high single-digit sales revenue growth and an EBITDA margin slightly above 30% by year-end. Order intake for consumables showed strong double-digit growth, while equipment sales were muted.

What is Earnings Call?
Fundamental Scores

SRT Profitability Score
Profitability Due Diligence

Sartorius AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
53/100
Profitability
Score

Sartorius AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

SRT Solvency Score
Solvency Due Diligence

Sartorius AG's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Average Altman Z-Score
35/100
Solvency
Score

Sartorius AG's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SRT Price Targets Summary
Sartorius AG

Wall Street analysts forecast SRT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRT is 296.48 EUR with a low forecast of 214.12 EUR and a high forecast of 367.5 EUR.

Lowest
Price Target
214.12 EUR
22% Upside
Average
Price Target
296.48 EUR
69% Upside
Highest
Price Target
367.5 EUR
109% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SRT?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SRT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SRT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Sartorius AG Logo
Sartorius AG

Country

Germany

Industry

Health Care

Market Cap

12.1B EUR

Dividend Yield

0.42%

Description

Sartorius AG is a DE-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 15,051 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.

Contact

NIEDERSACHSEN
Goettingen
Otto-Brenner-Str. 20
+495513080.0
www.sartorius.de

IPO

1999-04-01

Employees

15 051

Officers

Chairman of Executive Board & CEO
Dr. Joachim Kreuzburg
Head of Bioprocess Solutions Division & Member of Executive Board
Dr. Rene Faber
Head of the Lab Products & Services Division and Member of Executive Board
Dr. Alexandra Gatzemeyer
Head of Corporate Communications & Investor Relations and Member of Supervisory Board
Ms. Petra Kirchhoff
CFO & Member of Executive Board
Dr. Florian Funck Dipl.Kfm.
Head of Quality Assurance - Mechatronics Division Goettingen
Ms. Patricia Spannagel
Show More
Physicist & Head of Supply Chain Management - Germany
Ralf Mohrschladt
Head of Investor Relations
Ms. Petra Muller
President of Sartorius North America
Mr. Maurice Phelan
President of Environmental Technology Division
Dr. Theo Thijssen
Show Less

See Also

Discover More
What is the Intrinsic Value of one SRT stock?

The intrinsic value of one SRT stock under the Base Case scenario is 188.65 EUR.

Is SRT stock undervalued or overvalued?

Compared to the current market price of 175.8 EUR, Sartorius AG is Undervalued by 7%.

Back to Top